|
|
|
09/30/09
|
|
Treating Even Mild Gestational Diabetes Reduces Birth Complications
|
| A National Institutes of Health network study provided the first conclusive evidence that treating pregnant women who have even the mildest form of gestational diabetes can reduce the risk of common birth complications among infants, as well as blood pressure disorders among mothers. |
|
|
|
|
|
|
|
|
06/19/08
|
|
Surgeon General's Conference Outlines Agenda to Prevent Preterm Birth
|
| Experts convened by the National Institutes of Health for the Office of the Surgeon General released an agenda today for activities in the public and private sectors to reduce the nation’s rate of preterm birth. The agenda calls for a national system to better understand the occurrence of preterm birth and a national education program to help women reduce their chances of giving birth prematurely. |
|
|
|
|
05/07/08
|
|
Mothers' High Normal Blood Sugar Levels Place Infants at Risk for Birth Problems
|
| Pregnant women with blood sugar levels in the higher range of normal—but not high enough to be considered diabetes—are more likely than women with lower blood sugar levels to give birth to babies at risk for many of the same problems seen in babies born to women with diabetes during pregnancy, according to a study funded in large part by the National Institutes of Health. |
|
|
|
|
|
|
09/07/06
|
|
Molecules in Blood Foretell Development of Preeclampsia
|
| High levels of two proteins in the blood of pregnant women appear to indicate the subsequent development of preeclampsia, a life-threatening complication of pregnancy, report a team of researchers from the National Institutes of Health and Beth Israel Deaconess Medical Center. The proteins, which interfere with the growth and function of blood vessels, also signal the development of high blood pressure during pregnancy. |
|
|
09/06/06
|
|
Backgrounder - Pursuing the Causes of Preeclampsia
|
| The basic research effort to implicate soluble endoglin (sEng) and soluble fms-like tyrosine kinase 1 (sFlt-1) in preeclampsia was led by a coauthor of the current paper, S. Ananth Karumanchi, M.D., a nephrologist at the Beth Israel Deaconess Medical Center in Boston. |
|